Indication miebo ยฎ (perfluorohexyloctane ophthalmic solution) is indicated for the treatment of the signs and symptoms of dry eye disease. Important safety information miebo should not รขโ‚ฌยฆ Mieboรขโ€žยข is the first and only prescription medicine approved for the treatment of dry eye disease symptoms associated with mgd.

Discover miebo, the groundbreaking advancement in dry eye treatment. Experience innovative relief and transform your eye health. Learn more now! In june 2023 a new drop got fda approval for treating the signs and symptoms of dry eye disease: Miebo (100% perfluorohexyloctane). Instead of targeting inflammation as a pathway to dry eye relief, รขโ‚ฌยฆ Discover mieboยฎ, the first and only prescription eye drop that directly targets tear evaporation;

Miebo (100% perfluorohexyloctane). Instead of targeting inflammation as a pathway to dry eye relief, รขโ‚ฌยฆ Discover mieboยฎ, the first and only prescription eye drop that directly targets tear evaporation; The #1 cause of dry eye. Click to learn more!